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Megabase-scale copy number variants (CNVs) can have profound phenotypic consequences. Germline CNVs of this mag-
nitude are associated with disease and experience negative selection. However, it is unknown whether organismal function
requires that every cell maintain a balanced genome. It is possible that large somatic CNVs are tolerated or even positively
selected. Single-cell sequencing is a useful tool for assessing somatic genomic heterogeneity, but its performance in CNV
detection has not been rigorously tested. Here, we develop an approach that allows for reliable detection of megabase-scale
CNVs in single somatic cells. We discover large CNVs in 8%–9%of cells across tissues and identify two recurrent CNVs.We
conclude that large CNVs can be tolerated in subpopulations of cells, and particular CNVs are relatively prevalent within
and across individuals.
[Supplemental material is available for this article.]
Copy number variants (CNVs) can range in size from hundreds to
millions of base pairs. Copy number changes affect approximately
seven times as many base pairs as single-nucleotide variants and
are major contributors to inter-individual differences (Sudmant
et al. 2015). More than 65% of individuals harbor a germline
CNV of at least 100 kb, and at least 1% of individuals have a
CNV exceeding 1Mb (Itsara et al. 2009). Althoughmegabase-scale
CNVs could be considered collectively common, the specific CNVs
themselves are rare and often associated with disease (Girirajan
et al. 2011). Not surprisingly, large CNVs experience negative se-
lection, and their existence in a population is largely due to de
novo events (Itsara et al. 2010).
Although germline, megabase-scale CNVs are found in 1% of
individuals, the prevalence of somatic CNVs is only beginning to
be investigated. Array-based analyses of populations of cells from
many individuals provided initial insight into this question.
These studies identified megabase-scale somatic aberrations in up
to 4% of individuals; however, the sensitivity was limited to
CNVs present in >5% of cells (Forsberg et al. 2012; Jacobs et al.
2012; Laurie et al. 2012). These studies are thus blind to alterations
that arise late in development or adversely affect fitness, as this
would limit their propagation in a cell population.With the emer-
gence ofmethods to amplify the genome of a single cell, single-cell
sequencing nowprovides an alternatemeans of assessing the prev-
alence of somatic CNVs and offers the advantage of detecting
variants that exist in as few as one cell. Recently, two groups per-
formed low-coverage sequencing of single human neurons and re-
ported at least one megabase-scale CNV in >40% of neurons
(McConnell et al. 2013; Cai et al. 2014). These findings suggest
much greater tolerance of large somatic CNVs compared to germ-
lineCNVsandraise the interestingpossibility that somaticgenomic
heterogeneity contributes to phenotypic diversity within a tissue.
However, it is still unclear how CNV detection methods perform
when applied to individual cells, as single-cell sequencing poses
uniqueproblems forCNVdetection. First, single cells areusually se-
quenced at very low coverage. Second, genome representation in
the sequencing library can vary independently of copy number
due to inefficient and uneven genome fragmentation and amplifi-
cation. Moreover, any alterations identified in a single cell cannot
be verified by an independent method. Therefore, it is imperative
that appropriate quality control and analytic methods are used
such that the sensitivity (the likelihood that a real CNV of defined
size is detected) and specificity (the likelihood that a detected
CNV represents a real change in copy number) of an approach are
knownandoptimized in the context of single-cell sequencingdata.
Here, we use a variety of methods to quantify the sensitivity
and specificity of different approaches for megabase-scale CNV
detection in single-cell sequencing data. We develop an approach
with higher specificity than those used previously and use this ap-
proach to analyze single-cell sequencing data fromnormal human
brain and skin. From this analysis, we infer the prevalence of meg-
abase-scale CNVs across somatic tissues.
Results
Characterizing sequencing data from single somatic cells
We previously isolated single cells from fresh postmortem brain
and skin samples from four adults without neurologic or dermato-
logic disease (Knouse et al. 2014). Genomic DNA from a total of
105 brain cells (∼75% of which are neurons) from all four individ-
uals and a total of 55 keratinocytes from two of these individuals
were amplified by linker adapter PCR and sequenced at low cover-
age (0.1×) (Supplemental Table 1).
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To quantify variation in read depth across the genome and
identify cells suitable for analysis, we previously calculated a vari-
ability score (VS) for each cell (Knouse et al. 2014). The variability
score is generated by averaging the standard deviation in read
depth in sliding windows across each chromosome and averaging
the average standard deviation for the three autosomes with high-
est variability. Although this is suitable for whole-chromosome
copy number analysis, it could bias subchromosome copy number
assessment as copy number changes within each chromosome
could increase the VS. To assess the impact of CNVs on VS, we re-
calculated the VS of each cell by excluding windows with read
depths above or below threshold for diploid copy number. The
VS of only three of 160 cells changed when we excluded nondi-
ploid regions of the genome. In these three cells, the VS changed
by <0.02 (Supplemental Fig. 1A). This analysis indicates that
copy number changes are not responsible for the majority of
read depth variation. Regardless, we used the recalculated VS for
all subsequent analyses.
In our data set, the variability scores (VSs) ranged from 0.14 to
1.03, with a median of 0.19 and a long upper tail (Supplemental
Fig. 1B). The majority of cells with high VS were brain cells, and
the median VS in brain was significantly higher than in skin (0.2
versus 0.18, Mann-Whitney U test, P < 0.02). Cells with high VSs
were characterized by a wide spread of read depths across adjacent
genomicwindows (Supplemental Fig. 1C,middle panel) and/or an
abundance of segments with copy number changes, many of
which were non-integer and therefore incompatible with gains
and losses in a single cell (Supplemental Fig. 1C, bottom panel,
blue boxes). The VS is therefore an unbiased measure of sequenc-
ing data quality and a valid criterion for inclusion or exclusion
of a cell from copy number analysis.
Optimizing sensitivity and specificity of CNV detection
in single-cell sequencing data
To determine the prevalence of CNVs in brain and skin, we tested
twomethods for copy number analysis. Both approaches quantify
sequencing reads in genomic windows of ∼500 kb and adjust read
counts for mappability and GC bias within each window. The two
approaches differ in how copy number segments are inferred from
read depth in each window. One uses a hidden Markov model
(HMM) (Ha et al. 2012), whereas the other uses circular binary seg-
mentation (CBS) (Olshen et al. 2004). Both HMM and CBS feature
an adjustable parameter that determines the likelihood that a
change in copy number is identified. For HMM, the adjustable
parameter E dictates the probability of extending a segment of
defined copy number. Thus, as E is lowered, more copy number
changes are called. For CBS, the adjustable parameter α dictates
the significance level required to accept a change in copy number.
Therefore, higher levels of α allow for more copy number changes.
Changing the values of these two parameters therefore adjusts the
sensitivity and specificity of the two approaches.
To broadly test the performance of these two algorithms, we
simulated gains and losses ranging from 2.5 to 20 Mb in sequenc-
ing data from single cells with different variability scores. For each
cell, we determined the number of simulated and nonsimulated
CNVs that were detected by HMM and CBS at different values of
E and α. Several trends emerged. First, HMM had better sensitivity
for gains, and CBS had better sensitivity for losses (Supplemental
Fig. 1D, first and third panels). Second, overall sensitivity could
be increased by reducing E or increasing α, improving the detec-
tion of 2.5 and 5 Mb CNVs. Notably, doing so also resulted in
the detection of many nonsimulated CNVs, especially in cells
with high VS (Supplemental Fig. 1D, second and fourth panels).
Finally, for any algorithm at any parameter value, in cells with
VS > 0.3 therewas a dramatic reduction in the detection of simulat-
ed CNVs, especially gains, while as many as 100 nonsimulated
CNVs were identified (Supplemental Fig. 1D).
To test the sensitivity of these approaches to real CNVs,
we sequenced single fibroblasts from individuals known to har-
bor germline CNVs of defined size. All methods except HMM at
E = 0.9999999 reliably detected 10 and 20 Mb gains and losses,
whereas only HMM at E = 0.9 detected CNVs <5 Mb (Fig. 1A).
We conclude that CNVs 5Mb or larger can be detected bymultiple
approaches in single cells sequenced at 0.1× coverage.
Our simulations showed that algorithm sensitivity could be
adjusted to identify CNVs of <5Mb. However, this led to increased
detection of nonsimulated CNVs, suggesting that specificity was
compromised (Supplemental Fig. 1D, second and fourth panels).
In these simulation experiments, as with all single-cell sequencing
experiments, it is impossible to determine whether the nonsimu-
lated CNVs represent true CNVs undetectable at less sensitive pa-
rameters or false CNVs caused by random fluctuations in read
depth that are inappropriately identified as CNVswhen sensitivity
is increased. The next best way to verify CNVs is to sequence cells
that are closely related to one another, ideally the two products of a
cell division. Barring errors during DNA replication, two daughter
cells should have identical or complimentary CNVs. A CNV pre-
sent in only one of the cells, henceforth called a private CNV,
therefore likely represents a false positive CNVor a CNV that failed
to be detected in the other cell(s).
We expanded a single fibroblast in culture for approximately
seven divisions to yield approximately 100 cells and sequenced
five cells from this population. As any two cells in this population
have been genetically distinct for at most seven generations, most
CNVs should be shared by multiple cells. As a complimentary ap-
proach, we isolated single cells and split the cell contents in half
after cell lysis and DNA fragmentation but prior to whole-genome
amplification. As the lysis and fragmentation steps generate DNA
fragments ∼1000-fold smaller than the windows at which we bin
reads, the CNVs should be identical between the two samples.
For both of these experiments, we then calculated the proportion
of CNVs that were private in each cell or sample.
We were surprised to find that for most parameters of HMM
and CBS, over half of the identified CNVs were private (Fig. 1B).
Most of these private CNVs likely represent false CNVs, rather
than real CNVs that failed to be detected in related cells or samples,
because only 17% of private CNVs identified for a given algorithm
at a less sensitive parameter were subsequently identified in other
cells by the same algorithm using a more sensitive parameter.
Across all algorithms and parameters, the private CNVs ranged
in length from 0.5 to 34 Mb with the majority of private CNVs
(63%) <5 Mb (Fig. 1D). Not surprisingly, the least sensitive algo-
rithm and parameter, HMM at E = 0.9999999, was the most specif-
ic, with seven of nine cells lacking private CNVswhen analyzed by
this method. We also noted, especially in the split reactions, that
increasing HMM and CBS sensitivity led to reduced specificity
(Fig. 1B). Importantly, although in a given sample HMM or CBS
tended to identify the same private CNV at varying levels of sensi-
tivity, only 15%of private CNVswere identified by bothHMMand
CBS (Fig. 1E). All the private CNVs identified by both HMM and
CBS were unique to a given cell with the exception of a 20 Mb
gain on Chromosome 19, which was identified in four of the
nine samples. This CNV was not detected when cells were
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Figure 1. Testing sensitivity and specificity of CNV detection in single-cell sequencing data. (A) The discovery rate of known CNVs ranging from 3 to 20
Mb in single cells using HMM, CBS, or both at different values of E or α. Four or five cells were sequenced for each CNV. (B) The average proportion of CNVs
that are private in individual cells sharing a recent ancestor or DNA split after fragmentation from a single cell when analyzed by HMM, CBS, or both at
various parameters. (C ) The true discovery rates (for 5-Mb gains and losses) and the false discovery rates (averaged across samples from small population
or split amplification) for CNV detection using HMM, CBS, or both at different values of E or α, regardless of VS. (D) The distribution of private CNV type and
size in individual cells sharing a recent ancestor or DNA split after fragmentation from the same cell when analyzed by HMM, CBS, or both at various pa-
rameters. (E) The proportion of private CNVs called by more than one parameter of HMM or CBS and the proportion of private CNVs called by both HMM
and CBS.
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sequenced at higher (1×) coverage, indicating that it is an artifact
of low-coverage sequencing.
From these experiments, we conclude that private CNVs, the
majority of which we believe to be false CNVs, can occur at the
scale of megabases and can account for around half of all putative
CNVswhen algorithm parameters are adjusted to increase the sen-
sitivity to detect CNVs 5 Mb and smaller. Furthermore, we find
that HMM and CBS identify different private CNVs, suggesting
that using both algorithms simultaneously could enhance specif-
icity. Indeed, when we only considered CNVs detected by both
HMM at E = 0.995 and CBS at α = 0.0001 and ignored the common
gain on Chromosome 19, the prevalence of private CNVs fell to
zero in two of the five cells from a small population and all of
the split samples (Fig. 1B). Importantly, doing so did not compro-
mise the sensitivity for CNVs exceeding 5Mb (Fig. 1A).We decided
that the overlap of HMM and CBS at E = 0.995 and α = 0.0001, re-
spectively, afforded the best combination of sensitivity and specif-
icity for the purpose of detecting megabase-scale CNVs in somatic
cells. These parameters allow for the detection of all gains and loss-
es 10Mb and larger. Approximately half of 5-Mb CNVs can also be
detected, with losses more easily detected than gains (Fig. 1C).
Prevalence of somatic CNVs
We applied the combination of HMM and CBS at E = 0.995 and
α = 0.0001, respectively, to all brain and skin cells. We ignored
the gain on the proximal portion of Chromosome 19 that we
found to be an artifact of low sequencing coverage and only con-
sidered CNVs present on autosomes. In brain, but not skin, we ob-
served a positive correlation between the VS of a cell and the
number of CNVs identified (Pearson r = 0.53, P < 0.0001)
(Supplemental Fig. 2). Brain cells in the top tenth percentile for
VS contained 72% of all CNVs identified in brain (Fig. 2A). Thus,
the inferred CNV prevalence is strongly influenced by the cutoff
used to select cells for analysis (Fig. 2B,C).
Understanding the causality between VS and CNVs is crucial
given the positive correlation between a cell’s VS and the number
of CNVs in brain. High variability in read depth could lead to iden-
tification of CNVs that are not real. However, it is also possible that
many CNVs increase read depth variability. Several observations
argue against the latter. For one, when we recalculated VSs by ex-
cluding CNVs, the VSs hardly changed, indicating that the many
CNVs in cells with high VS are not solely responsible for the high
VS. Indeed, much of the variation in read depth in cells with
high VS came in the form of fluctuations within the range of dip-
loid copy number (Supplemental Fig. 1C, blue boxes). Further-
more, our data set includes a brain cell with six CNVs and a VS of
only 0.22 (Supplemental Fig. 2, arrow), indicating that high VS is
not an obligatory consequence of harboring many CNVs.
The preceding observations suggest that high VS is secondary
to reasons other than variation in copy number, and many CNVs
identified in such cells are likely to be false. Our private CNV anal-
ysis supports this hypothesis. The number of private CNVs was
much higher in cells with high VS (Fig. 1B). Moreover, our simula-
tions indicated that the sensitivity of CNV detection drops as
VS exceeds 0.3 (Supplemental Fig. 1D, first and third panels).
Because high VS not only complicates detection of real CNVs
but also increases the discovery of false CNVs, we only considered
cells withVS of <0.26 for our analysis (Fig. 2A, dashed line). This VS
value renders the brain and skin cells equivalent in VS distribution
(mean = 0.19 for both tissues).When applying HMMand CBS at E
= 0.995 and α = 0.0001, respectively, to cells with VS < 0.26, we ex-
pect to detect 20%of 5-Mb gains, 75%of 5-Mb losses, and all CNVs
10 Mb and larger with a false discovery rate of <17% (Fig. 1). Of
132 brain and skin cells with VS < 0.26, we identified a total of
23 CNVs distributed across seven brain and four skin cells (Fig. 3;
Supplemental Table 2).
Validation of somatic CNVs
Although the nature of single-cell sequencing renders it impossi-
ble to validate theCNVs identified in a single cell by an orthogonal
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Figure 2. Relationship between variability score and CNV prevalence.
(A) The variability scores for all brain and skin cells sequenced. The number
adjacent to a given point or group of points indicates the total number of
CNVs identified in that cell or group of cells. The dashed line indicates a VS
cutoff of 0.26. (B) The percentage of brain and skin cells harboring at least
one megabase-scale CNV using different VS cutoffs to exclude cells from
analysis. (C) The distribution of the total number of megabase-scale
CNVs per cell in brain and skin using different VS cutoffs to exclude cells
from analysis.
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method, we usedmultiple analyses to increase our confidence that
the CNVs we identified represent true gains and losses of genomic
material. First, we resequenced four cells identified to have 6, 5, 3,
and 1CNVs and two cells with no CNVs at 10-fold higher coverage
(1×). This analysis revealed that our CNV identification parameters
are robust. The two cells without CNVs did not have any CNVs
upon increased coverage. Furthermore, 87% of CNVs identified
in cells at 0.1× coverage were also identified in cells at 1× coverage
(Supplemental Table 3). Two small (<5.5 Mb) CNVs identified at
0.1× coverage were no longer detected at 1× coverage, and four
small (<3 Mb) CNVs were identified at 1× coverage that were not
detected at 0.1× coverage (Supplemental Table 3).
Resequencing cells at higher coverage allowed us to look for
loss of heterozygosity (LOH) in putative deletions. We pooled all
cells sequenced from each individual to identify single-nucleotide
polymorphisms (SNPs) forwhich the individual was heterozygous.
We then determined the state of these heterozygous SNPs in the
cells sequenced at higher coverage. We first measured the distance
between two successive heterozygous SNPs outside the regions of
putative deletion in the single cells. These distances ranged from
2 bp to 58 Mb with a median of 2.8 Mb (Supplemental Fig. 3A).
We then calculated the distance betweenheterozygous SNPs flank-
ing (and, if present, within) putative deletions. The distance be-
tween heterozygous SNPs flanking/inside putative deletions was
significantly higher than the distance between heterozygous
SNPs outside putative deletions for two of the three cells (Mann-
Whitney U test, P = 0.014, P < 0.0001) (Supplemental Fig. 3A).
Encouraged by this result, we analyzed the state of SNPs within
the putative deletions. At 1× coverage, the status of only a handful
of SNPs could be assessed in each putative deletion. However,
when we combined all SNPs for the 13 putative deletions that
could be analyzed, there was a significant depletion of heterozy-
gous SNPs within the putative deletions compared to outside the
alleged deletions (Fisher’s exact test, P = 0.0001). Nine of the 13 pu-
tative deletions did not harbor a single heterozygous SNP
(Supplemental Fig. 3B). The remaining four deletions had a single
heterozygous SNP. For one of these deletions, a loss on the proxi-
mal portion of Chromosome 8, the heterozygous SNP occurred
within the first 500 kb of the putative deletion and thus could
be a consequence of binning reads in ∼500 kb windows. For two
other deletions, the heterozygous SNP was within at least 1.5 Mb
of one boundary. This suggests that the CNV either was identified
incorrectly or that there are two deletions joined by a small region
of normal copy number. Finally, one heterozygous SNP was iden-
tified in a deletion that was not detected upon sequencing at high-
er depth, further supporting the conclusion that this deletion is
not real.
We also analyzed 13 putative deletions in two cells with
VS > 0.26. As before, we observed a significant increase in the dis-
tance between heterozygous SNPs within deletions as compared
to outside deletions for both cells (Mann-Whitney U test, P =
0.0013, P < 0.0001) (Supplemental Fig. 3C). However, of the 13 de-
letions, only three lacked heterozygous SNPs, and therewas no sig-
nificant depletion of heterozygous SNPs within the putative
deletions compared to outside these deletions (Fisher’s exact test,
P = 0.892) (Supplemental Fig. 3D). Together, our SNP analysis re-
vealed that in low-coverage, single-cell sequencing data, continu-
ous homozygosity can span megabases even in allegedly euploid
regions. Thus, loss of heterozygous SNPs cannot rigorously con-
firm megabase-scale deletions, but the identification of heterozy-
gous SNPs can identify false deletions. The significant increase in
the distance between heterozygous SNPs flanking/inside deletions
combined with the significant decrease in heterozygous SNPs
within deletions in our data set supports but does not prove their
existence. However, the identification of heterozygous SNPs with-
in many of the deletions from cells excluded from analysis under-
scores the association between high VS and false CNVs and
justifies the exclusion of such cells from analysis.
1 2 3 4 5 6 7 8 9 10 11 12
13 14 15 16 17 18 19 20 21 22
Gain
Loss
Figure 3. Megabase-scale CNVs in somatic cells. Karyogram showing the 23 gains and losses identified across 80 brain cells and 52 skin cells with VS
<0.26. Gains and losses are represented by red and blue bars, respectively.
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Although loss of heterozygosity is consistent with a deletion,
it cannot distinguish a true genomic deletion from loss of DNA
during cell lysis or whole-genome amplification. However, in con-
trast to loss of DNA during whole-genome amplification, most
mechanisms that would generate true genomic deletions would
join two previously separated regions of the genome. This juxtapo-
sition could be identified by paired-end sequencing, assuming the
fragment containing the junction did not drop out during whole-
genome amplification. To determine whether we could identify
such chimeric DNA fragments, we resequenced one cell harboring
multiple deletions to 2× coverage with paired-end reads. We iden-
tified multiple (3–5) discordant reads flanking the breakpoints
for half the deletions. However, we also identified thousands of
discordant reads mapping to distant positions within and across
chromosomes in allegedly euploid regions, and in some cases, a
handful mapped to similar positions as they did for half of the pu-
tative deletions. We suspect this is due to chimera formation dur-
ing whole-genome amplification. In light of the not insignificant
probability that junction fragments drop out during whole-ge-
nome amplification (low signal), the high level of discordant reads
in euploid regions (high background), and the financial costs asso-
ciated with resequencing at higher coverage, we concluded that
paired-end sequencing is not a viable approach for validating
CNVs identified across many single cells. In summary, although
SNP analysis can provide supporting evidence for the existence
of deletions, it remains difficult to validate putative CNVs identi-
fied across many cells. This emphasizes the importance of using
a CNV detection algorithm thatminimizes the false discovery rate.
Characteristics of somatic CNVs
Using the CNVs detected by our empirically validated detection al-
gorithm and exclusion criteria (Fig. 3; Supplemental Table 2), we
went on to characterize the CNVs identified in brain and skin.
To avoid biasing the data, we kept the two deletions that disap-
peared at higher sequencing depth in our data set and did not in-
corporate the four additional CNVs identified at higher depth. Our
analysis revealed that 9% of brain cells and 8% of skin cells harbor
at least one megabase-scale CNV (Fig. 2B). Across the individuals
we analyzed, the prevalence of cells harboring megabase-scale
CNVs ranged from 0% to 20% in brain and 4% to 11% in skin
(Supplemental Fig. 4). Interestingly, CNVoccurrencewas not inde-
pendent, as the 23 CNVs were distributed among only 11 of 132
cells (Poisson P < 10−5) (Fig. 2C). Losses were muchmore common
than gains, but given that one of the gains comprised an entire
chromosome arm, losses affected only slightlymore of the genome
(186.23Mb of losses versus 137.4Mb of gains) (Fig. 4A). Telomeric
CNVs were highly enriched (Fisher’s exact test, P < 0.0001), with
11 of the 23 CNVs extending to the telomere.
To determine whether CNVs or their boundaries shared cer-
tain characteristics, we independently tested whether each CNV
and a 1-Mb region centered at each CNV boundary (or the first
0.5 Mb of a telomeric boundary) were enriched for various geno-
mic features compared to a random genomic region of equivalent
size. Thirty-five percent of CNVs were enriched for at least one
type of repetitive sequence, such as SINEs, LINEs, DNA repeat ele-
ments (i.e., DNA transposons), and noncoding RNAs (i.e., tRNA,
rRNA, snRNA, scRNA, and srpRNA) (Fig. 4B). CNV boundaries
were even further enriched for repetitive sequence, with 54% of
boundaries enriched for at least one of these elements. Although
CNV boundaries often had repetitive elements, only two CNVs
showed enrichment for the same type of repetitive sequence at
both boundaries (noncoding RNA in both cases). Additionally,
eight boundaries (17% of all boundaries) were enriched for seg-
mental duplications, with seven of these boundaries occurring at
telomeres. However, no CNVs were enriched for segmental dupli-
cations at both boundaries.
In light of the low CNV burden—we identified 23 CNVs that
in total comprise only 324 Mb (∼10%) of the genome—we were
surprised to find two CNVs that recurred with nearly identical co-
ordinates in at least two cells. The first was an ∼7-Mb loss on the
proximal portion of Chromosome 5 in two brain cells from two
different individuals (Fig. 3; Supplemental Table 2). The second
was an ∼5-Mb loss on the proximal portion of Chromosome 8 in
two brain cells from the same individual and one skin cell from a
different individual. This region of Chromosome 8 has previously
been identified as a rearrangement hotspot because of an abun-
dance of segmental duplications at chromosome coordinates 0,
1, 7, and 8 Mb that predispose this region to nonallelic homolo-
gous recombination (Bailey et al. 2002; Yu et al. 2010). A study
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of 1000 individuals with developmental defects revealed mega-
base-scale CNVs on the proximal portion of Chromosome 8 in
1% of patients (Yu et al. 2010). This region of Chromosome 8
has also been identified as a peak region of deletion acrossmultiple
tumor types and contains the tumor suppressor CSMD1 (Ma et al.
2009; Midorikawa et al. 2009; Zack et al. 2013). In light of these
preexisting data, it seems likely that CNVs in this region occur
more frequently, and perhaps provide a selective advantage, at
the somatic level.
Discussion
Low coverage sequencing of single cells is emerging as a popular
and powerful tool to assess genomic heterogeneity in health and
disease. However, it has been unclear what types of variants can
be detected and, more importantly, what the likelihood is that
the detected variants are real. Through a combination of in silico
and in vivo approaches, we assessed the sensitivity and specificity
of a variety of analytical approaches for CNV detection in low cov-
erage, single-cell sequencing data. We developed an approach that
allows for the robust yet specific detection of CNVs exceeding
5 Mb. We applied this approach to single-cell sequencing data
from brain and skin to provide, to our knowledge, the first assess-
ment of somatic CNVs in multiple tissues at genome-wide, single-
cell resolution. We find that ∼10% of somatic cells harbor at least
one megabase-scale CNV regardless of tissue of origin.
Our analysis shows that the specificity of CNV detection is
extremely compromised when algorithm parameters are adjusted
to detect CNVs <5 Mb and when cells exhibiting high variability
in read depth are analyzed. In these cases, false positive CNVs
can account formore than half of CNVs detected. This can explain
the much higher prevalence of CNVs reported for neurons in two
recent single-cell sequencing studies. McConnell et al. (2013) se-
quenced 110 neurons at ∼0.1× coverage and identified mega-
base-scale CNVs in 45 (41%) of these cells. Their data set
included 14 cells with VS > 0.26, and CNVs were detected using
CBS with α = 0.001. When we reanalyzed their data using our VS
cutoffs and overlapping algorithms, we identified megabase-scale
CNVs in 17% of cells. Cai et al. (2014) sequenced 26 neurons at
∼0.08× coverage, 19 of which they analyzed, and 13 (68%) of
these cells were reported to harbor megabase-scale CNVs. In their
data set, 16 cells had VS >0.26, and CNVs were detected using
CBS with α = 0.02. When we analyzed the 10 cells with VS < 0.26
by our approach, we identified CNVs in only one neuron. Thus,
the differences between our results and those reported by
McConnell et al. (2013) and Cai et al. (2014) can be attributed to
differences in analytic methods rather than differences in the
cell populations.
We acknowledge that the majority of cells we excluded with
VS > 0.26 were from brain. Thus, it is possible that the brain has
a subset of cells with high CNV burden that was excluded from
our data set. However, we believe that including cells with high
VS is more likely to generate artifacts than to report on true
CNVs for several reasons. For one, our specificity experiments
show that cells with higher VS have a greater proportion of false
CNVs. Moreover, our analysis of SNPs in cells with high VS re-
vealed that the majority of their putative deletions were false.
Finally, we note that CNVs do not appear to be responsible for
high VS, and much of the variability in these cells is in the form
of non-integer copy number changes. It is unclear why high VSs
are more common in brain than skin but could reflect biological
differences in chromatin structure that affect the efficiency of
whole-genome amplification. Until we better understand the bio-
logical and/or technical origin of highVS,wemust assume that the
high CNV burden in cells with high VS is an artifact.
Our approach generated a data set of high confidence, mega-
base-scale somatic CNVs, leading to several conclusions about
somatic copy number variation. First, we observe 10-fold more
losses than gains. However, because one gain was much larger
than all other CNVs, losses and gains affected a similar amount
of the genome. We note the increased frequency of losses com-
pared to gains could be secondary to our approach having better
sensitivity to losses for CNVs <10 Mb. Second, somatic CNVs are
not distributed uniformly throughout the genome but instead
tend to occur at telomeres. Many of the CNVswere enriched for re-
petitive sequence such as SINEs, LINEs, DNA repeat elements, and
noncoding RNAs. Presumably CNVs affecting repetitive sequence
are better tolerated than CNVs enriched for coding sequence.
More than 20% of germline CNVs are associated with seg-
mental duplications, and it is believed that nonallelic homologous
recombination among these segmental duplications or other re-
petitive sequences is a common source of germline duplications
and deletions (Sharp et al. 2005; Redon et al. 2006). On the other
hand, high-resolution analyses of cancer genomes point to non-
homologous end joining and alternative end joining as the prima-
ry source of somatic deletions in tumors (Yang et al. 2013). We
observed enrichment for repetitive sequences and segmental du-
plications at the boundaries of somatic CNVs, suggesting that non-
allelic homologous recombination might also underlie somatic
structural variation in nontransformed cells. However, only two
CNVs were enriched for the same class of repetitive sequence at
both breakpoints and noCNVswere flanked by segmental duplica-
tion on both sides. With limited resolution at breakpoints and
without obvious repetitive sequence flanking both boundaries of
most CNVs, we are unable to implicate specific molecular mecha-
nisms in generating somatic CNVs in healthy tissues.
We were surprised to find two recurrent CNVs, deletions on
the proximal portions of Chromosomes 5 and 8, in two and three
cells, respectively. The deletion on Chromosome 8 thus occurs in
2% of all cells analyzed and accounts for 13% of all the CNVs we
detected. That this particular CNV has been previously identified
inmultiple population-based copynumber analyses andwas never
identified as a private CNV in our study further increases our con-
fidence that this loss represents a real, recurrent CNVas opposed to
a single-cell sequencing artifact. Moreover, its presence at the indi-
vidual level and in cancer suggests that it not onlymay be prone to
arising because of local genome structure but may also provide a
selective advantage for cells that harbor it.
We find that megabase-scale CNVs are 10 times more preva-
lent at the somatic level compared to the organismal level. This
suggests that these aberrations arise more frequently in mitotic
cells and/or, more likely, that these changes are better tolerated
when they occur sporadically in tissues. However, like germline
CNVs, somatic CNVs show an inverse relationship between
CNV size and prevalence. In this current analysis, we observe
whole-chromosome copy number changes in 0.8% of cells. Sub-
chromosome CNVs exceeding 10 Mb are present in 1.5% of cells,
and CNVs between 5 and 10 Mb are found in 3.8% of cells.
Extrapolating to events beyond our detection limit of 5Mb, we ex-
pect that >15% of cells harbor CNVs smaller than 5 Mb.
Wepresent and validate an approach that allows for detection
of megabase-scale CNVs with high specificity in low coverage sin-
gle-cell sequencing data. With this approach, we now have the
power to address various questions of genomic heterogeneity in
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health and disease. It remains to be determined whether somatic
CNVs accumulate with age and whether cells harboring these
changes will undergo further transformation or contribute to tis-
sue dysfunction. Sequencing cells at much higher coverage, which
will necessitate collaboration across multiple groups and financial
sources, will enable the characterization of even smaller variants.
Further technological development catered toward single-cell se-
quencing will also help to enhance the sensitivity and specificity
at any coverage level.
Methods
Tissues, cell lines, and sequencing data
The tissue sources were described previously (Knouse et al. 2014).
The following cell lines harboring known CNVs were obtained
from the NIGMS Human Genetic Cell Repository at the Coriell
Institute for Medical Research: GM10374, GM05401, GM08263,
GM05875, GM06801, GM13330, GM08696, and GM03918.
Data from McConnell et al. (2013), Cai et al. (2014), and
Knouse et al. (2014) were downloaded from the National Center
for Biotechnology Information Sequence Read Archive using
accession numbers SRP030642, SRP051114, and SRP041670,
respectively.
Single-cell whole-genome amplification and sequencing
Single-cell isolation, whole-genome amplification, and sequenc-
ing were performed as previously described (Knouse et al. 2014)
with the following modifications. To sequence cells from a small
population, single fibroblasts from GM08696 were transferred to
individual wells of a 96-well plate using a homemade microaspira-
tor. The cells were cultured until approximately 100 cells were pre-
sent in a single well, at which point the contents of the well were
harvested by trypsinization, and individual cells were prepared for
sequencing. To sequence two separate amplifications of a single
cell, the solution containing a lysed and fragmented cell was split
into two separate tubes of equal volume. Both tubes were then sub-
jected to whole-genome amplification using a half volume of each
subsequent reagent.
Quality control
Variability scores (VSs) for all cells were calculated previously
(Knouse et al. 2014). To recalculate VS with CNVs excluded, win-
dows with read depth at log2 ratios above the threshold for gain
or loss were eliminated from the calculation.
CNV simulation
Sequencing data from 12 samples with different VSs were used as
input. To simulate copy number loss, we randomly down-sampled
half the reads in the desired CNV interval. To simulate copy num-
ber gain, all the reads in the desired CNV region were retained
while one-third of the reads outside the window were removed.
Functions implemented in SAMtools (version 0.1.19) (Li et al.
2009) and BEDTools (version 2.17.0) (Quinlan and Hall 2010)
were used in the region sampling. The lengths of these simulated
CNVs varied from 2.5 to 20 Mb and, for each length, five CNVs
were simulated throughout the genome. These modified sequenc-
ing datawere then analyzed forCNVs as described below.ACNVof
defined size was considered detectable if it was identified in at least
three of five cases in a single cell.
CNV detection using HMM
Sequence reads were trimmed to 40 nucleotides and aligned to the
major chromosomes of human (hg19) using BWA (version 0.6.1)
(Li and Durbin 2009) with default options. HMMcopy (version
0.1.1) (Ha et al. 2012) was used to detect CNVs by estimating
copy number in 500-kb bins controlling for mappability (down-
loaded from UCSC Genome Browser; http://hgdownload.cse.ucsc.
edu/goldenPath/hg19/encodeDCC/wgEncodeMapability/) and GC
content (calculated by HMMcopy gcCounter). The parameter E
was varied from default (E = 0.9999999) to E = 0.995, 0.99, 0.95,
and 0.9 for testing. Log2 cutoffs of 0.4 and −0.35 were used for
gains and losses, respectively. These cutoffs were set just below
the minimum log2 ratio at which known CNVs were observed.
CNV detection using CBS
Themappability track (http://hgdownload.cse.ucsc.edu/goldenPath/
hg19/encodeDCC/wgEncodeMapability/wgEncodeCrgMapability
Align40mer.bigWig) downloaded from UCSC Genome Browser
was processed to define dynamic windows containing 500-kb
uniquely mapped locations in each window as previously described
(McConnell et al. 2013). The GC percentages were computed
for these windows. The reads were first mapped by BWA (version
0.6.1), and uniquely mapped reads were kept. PCR duplicates were
then removed using MarkDuplicates from Picard (version 1.94).
Read counts in the dynamic windows were summarized by
BEDTools (version 2.17.0) coverageBed (Quinlan and Hall 2010).
Readcount in each window was normalized by the genome-wide
median read count of all windows with similar GC percentage,
as measured in 1% intervals, then multiplied by 2 (McConnell
et al. 2013). Log2 ratios were then used as input for DNAcopy in
R (Olshen et al. 2004). The parameter α in the DNAcopy package
was varied (0.0001, 0.001, 0.01, and 0.05) for testing. Cutoffs of
1.32 and 0.6 were used for gains and losses, respectively.
CNV detection using both algorithms
Sequencing data from each cell were independently processed
by the two methods described above at the specified values of E
and α. A CNVwas called only in regions in which both algorithms
identified a CNV of the same type (loss or gain). If the two algo-
rithms identified the same CNV but the boundaries differed, the
coordinates of overlap were set as the boundaries of the CNV.
SNP analysis
SAMtools (version 0.1.19) mpileup and BCFtools (Li et al. 2009)
were used to identify variants in the BAM alignment output.
VCFtools (version 0.1.8a) vcf-annotate (Danecek et al. 2011) was
then used to match these variants to dbSNP build 138 (Sherry
et al. 2001). For pooled samples, a mapping quality score of
30 and a read depth of 4 were required to identify heterozygous
SNPs. The DP4 tags in the VCF files were used to characterize the
status of known SNPs that are not located in repetitive regions de-
fined by RepeatMasker track downloaded from UCSC Genome
Browser.
Enrichment analysis
To test for telomere enrichment, BEDTools shuffle was used to
identify 10 random regions of the genome that were the same
length as each CNV in our data set. The location of these 230 co-
ordinates was then compared to the location of the 23 CNVs.
To test for enrichment of other genomic features, the following
BED format annotation files were downloaded from UCSC
Genome Browser: segmental duplications (Segmental Dups),
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repeats (RepeatMasker), CpG islands (cpgIslandExt), and genes
(refGene). Fragile sites identified by a previous study (Fungtamma-
san et al. 2012) were extracted and lifted over to hg19. BEDTools
was used to overlap the CNVs and their boundaries to these anno-
tation files and count the number of features permillion base pairs.
These densities were compared with the background feature densi-
ties throughout the whole genome, and Z-scores for each were cal-
culated. ACNV or boundary was considered significantly enriched
or depleted for a given feature if the Z-score was greater than 1.96
or less than −1.96, respectively.
Data access
The additional sequencing data generated in this study (cells har-
boring known CNVs, cells sharing a recent ancestor, DNA split af-
ter fragmentation from a single cell, and cells resequenced at
higher coverage) have been submitted to the NCBI Sequence
Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra/) under ac-
cession number SRP041670.
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